- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07320937
Effects of Yiqi Fuyuan Paste Formula in Chronic Fatigue Syndrome: A Randomized Double-Blind Controlled Clinical Trial.
The goal of this clinical trial is to learn if "Yiqi Fuyuan Paste Formula" (a traditional Chinese medicinal paste made from medicinal and edible Chinese medicines and health food like Ginseng Radix et Rhizoma, Astragali Radix et Rhizoma, Codonopsis Radix, Atractylodis Macrocephalae Rhizoma, Poria Cocos, Coicis Semen, Dioscoreae Rhizoma, Nelumbinis Semen, Angelicae Sinensis Radix, Lycii Fructus, Citri Reticulatae Pericarpium, Juglandis Semen, Longan Arillus, Sesami Nigri Semen, Jujubae Fructus, Glycyrrhizae Radix et Rhizoma, and fine ingredients) works to ease Chronic Fatigue Syndrome (CFS) symptoms in adults. It will also learn about the safety of "Yiqi Fuyuan Paste Formula". The main questions it aims to answer are:
- Does "Yiqi Fuyuan Paste Formula" help reduce CFS-related fatigue (measured by the Fatigue Assessment Instrument, FAI)
- What underlying bodily changes (shown in blood tests) might explain its effects.
Researchers will compare "Yiqi Fuyuan Paste Formula" to a placebo (a look-alike substance that contains no drug) to see if "Yiqi Fuyuan Paste Formula" works to ease CFS symptoms.
Participants will:
- Take "Yiqi Fuyuan Paste Formula" or a placebo every day for 2 months
- Visit the clinic before and after the intervention for checkups and tests
- Keep a diary of their symptoms
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pudong New Area
-
Shanghai, Pudong New Area, China, 201203
- ShuGuang Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Age range: 18 - 65 years old, gender not restricted;
Patients meeting the diagnostic criteria for chronic fatigue syndrome;
- Patients identified as having an "qi deficiency" or "balanced" constitution according to traditional Chinese medicine body type assessment; ④ Voluntary participants who have signed the informed consent form.
Exclusion Criteria:
Those who have any of the following conditions will not be included in this trial.
Those with severe depression or other mental disorders, as well as severe diseases of the heart, brain, liver, kidney and hematopoietic system; ② Those who are known to be allergic to the ingredients used in the ointment and have a severe allergic constitution;
- Women who are currently breastfeeding, pregnant or have the intention to get pregnant during the trial period; ④ Those who are currently participating in other medical clinical trials.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
Placebo, oral, twice daily for 8 weeks
|
Method of taking the ointment: Start taking it from the time it is prepared.
It is generally recommended to take it on an empty stomach.
The total duration of taking it is 8 weeks (20g per dose, twice a day), taking it warm in the morning and evening respectively; The ointment should be stored in the refrigerator for refrigeration.
|
|
Experimental: "Yiqi Fuyuan Paste Formula" test group
Yiqi Fuyuan Paste Formula, oral, twice daily for 8 weeks
|
The intervention is a custom-made herbal paste prepared from food-medicine homology ingredients, including Astragalus membranaceus, Codonopsis pilosula, Dioscorea opposita, and others. It is administered orally twice daily for 12 weeks to improve immune function and quality of life in patients with chronic fatigue or post-illness recovery. Method of taking the ointment: Start taking it from the time it is prepared. It is generally recommended to take it on an empty stomach. The total duration of taking it is 8 weeks (20g per dose, twice a day), taking it warm in the morning and evening respectively; The ointment should be stored in the refrigerator for refrigeration. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
FAI (Fatigue Assessment Instrument)
Time Frame: week4
|
week4
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
SF-36 (The MOS 36-Item Short-Form Health Survey)
Time Frame: week4
|
week4
|
|
QDC(Qi deficiency constitution score)
Time Frame: week4
|
week4
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
inflammatory factors
Time Frame: week 4
|
Changes in inflammatory factors(IL-2, IL-6, IL-10, IgA, IgM, INF-γ TNF-α) through peripheral serum
|
week 4
|
|
Differential genes
Time Frame: week 4
|
Screening of differentially expressed genes through RNA-seq
|
week 4
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2024-1603-186-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CFS
-
University of Alabama at BirminghamPosit Science Corporation; UAB College of Arts and Sciences & Department of...Not yet recruitingCognitive Impairment | Cognitive Dysfunction | Chronic Fatigue Syndrome (CFS) | ME/CFS | Chronic Fatigue | Brain Fog | ME/CFS Following EBV-associated Infectious Mononucleosis | ME/CFS Following COVID-19United States
-
Technical University of MunichCharite University, Berlin, GermanyRecruitingME/CFS | CFS/ME | ME/CFS Following EBV-associated Infectious Mononucleosis | ME/CFS Following COVID-19Germany
-
Charite University, Berlin, GermanyGerman Federal Ministry of Research, Technology, and Space (BMFTR); Weidenhammer-Zöbele...RecruitingME/CFS Following COVID-19 | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Germany
-
The University of Hong KongInnovation and Technology Commission, Hong KongNot yet recruitingChronic Fatigue Syndrome (CFS) | Post-COVID ME/CFSHong Kong
-
Charite University, Berlin, GermanyCompleted
-
Practitioners Alliance NetworkUnknown
-
University Hospital, LinkoepingCompletedFrailty | Frailty Syndrome | Emergency Department | Geriatric Assessment | CFSSweden
-
National Center for Complementary and Integrative...RecruitingCancer | Fatigue | Lupus | CFS | ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Systemic Lupus Erthematosus | SjogrensUnited States
-
Charite University, Berlin, GermanyCompletedImmunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFSME/CFS | Post-COVID ME/CFSGermany
Clinical Trials on Placebo(a look-alike substance that contains no drug)
-
Xinqiao Hospital of ChongqingThe First Affiliated Hospital of Nanchang University; China Shijiazhuang Pharmaceutical...RecruitingStroke, Acute IschemicChina
-
University of British ColumbiaVancouver Coastal Health Research InstituteTerminatedCritical Illness | FeverCanada
-
St. Jude Children's Research HospitalCompletedHealthy ParticipantsUnited States
-
Stanford UniversityWithdrawnDepression | Major Depressive Disorder
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)CompletedEpendymoma | Craniopharyngioma | Germ Cell Tumor | Glioma of BrainUnited States
-
Medical University of WarsawChildren's Memorial Health Institute, PolandRecruitingDiabetes Mellitus, Type 1Poland
-
Bangor UniversityUnknownRheumatoid ArthritisUnited Kingdom
-
Eunice Kennedy Shriver National Institute of Child...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes | Endocrine DiseaseUnited States
-
Plethora Solutions LtdShionogi Inc.CompletedPremature EjaculationUnited States
-
Manhattan Physical Medicine and Rehabilitation,...RecruitingScoliosis Idiopathic | Scoliosis; Adolescence | Scoliosis; Lumbar RegionUnited States